Search Results - Ian D. Lewis

Refine Results
  1. 1
    Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system

    Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system by Ian D. Lewis, Graça Almeida‐Porada, Jingbo Du, Ihor R. Lemischka, Kateri Moore, Esmail D. Zanjani, Catherine M. Verfaillie

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade

    GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade by Tessa Gargett, Wenbo Yu, Gianpietro Dotti, Eric Yvon, Susan N. Christo, John D. Hayball, Ian D. Lewis, Malcolm K. Brenner, Michael P. Brown

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    An optimized algorithm for detecting and annotating regional differential methylation

    An optimized algorithm for detecting and annotating regional differential methylation by Sheng Li, Francine E. Garrett-Bakelman, Altuna Akalin, Paul Zumbo, Ross L. Levine, Bik L To, Ian D. Lewis, Anna Brown, Richard J. D’Andrea, Ari Melnick, Christopher E. Mason

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

    Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice by E. M. Lee, Dean Y. Yee, SJ Busfield, Julie F. McManus, Nik Cummings, G Vairo, Andrew H. Wei, Hayley S. Ramshaw, Jason A. Powell, Angel F. López, Ian D. Lewis, M. N. McCall, Richard B. Lock

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Dynamic evolution of clonal epialleles revealed by methclone

    Dynamic evolution of clonal epialleles revealed by methclone by Sheng Li, Francine E. Garrett-Bakelman, Alexander E. Perl, Selina M. Luger, Chao Zhang, Bik L To, Ian D. Lewis, Anna Brown, Richard J. D’Andrea, M. Elizabeth Ross, Ross L. Levine, Martin Carroll, Ari Melnick, Christopher E. Mason

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome

    Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome by Deepak Singhal, Monika Kutyna, Rakchha Chhetri, Li Yan A. Wee, Sophia Hague, Lakshmi Nath, Shriram V. Nath, R. K. Sinha, Nicholas Wickham, Ian D. Lewis, David M. Ross, Peter Bardy, Luen Bik To, John Reynolds, Erica M. Wood, David Roxby, Devendra Hiwase

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia

    Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia by Jason A. Powell, Alexander C. Lewis, Wenying Zhu, John Toubia, Melissa R. Pitman, Craig T. Wallington‐Beddoe, Paul A.B. Moretti, Diana Iarossi, Saumya E. Samaraweera, Nik Cummings, Hayley S. Ramshaw, Danièl Thomas, Andrew H. Wei, Angel F. López, Richard J. D’Andrea, Ian D. Lewis, Stuart M. Pitson

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia

    A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia by Simon He, Samantha J. Busfield, David Ritchie, Mark Hertzberg, Simon Durrant, Ian D. Lewis, Paula Marlton, Andrew J. McLachlan, Ian Kerridge, Kenneth F. Bradstock, Glen Kennedy, Andy Boyd, Trina Yeadon, Angel F. López, Hayley S. Ramshaw, Harry Iland, Simone Bamford, Megan Barnden, Mark DeWitte, Russell L. Basser, Andrew W. Roberts

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

    Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients a... by Mark Hertzberg, Maher K. Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir‐Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D. Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, Andrew Wirth, John F. Seymour, Michael S. Hofman, Rodney J. Hicks

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

    Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia by Christopher N Hahn, Chan‐Eng Chong, Catherine Carmichael, Ella Wilkins, Peter J Brautigan, Xiaochun Li, Milena Babic, Ming Lin, Amandine Carmagnac, Young Kyung Lee, Chung Hoow Kok, Lucia Gagliardi, Kathryn Friend, Paul G. Ekert, Carolyn M Butcher, Anna Brown, Ian D. Lewis, L.B. To, Andrew E. Timms, Jan Storek, Sarah Moore, Meryl Altree, Robert Escher, Peter Bardy, Graeme Suthers, Richard J. D’Andrea, Marshall S. Horwitz, Hamish S. Scott

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffus... by Myron S. Czuczman, Marek Trněný, Andrew Davies, Simon Rule, Kim Linton, Nina D. Wagner‐Johnston, Randy D. Gascoyne, Graham W. Slack, Pierre Brousset, David A. Eberhard, Francisco J. Hernandez‐Ilizaliturri, Gilles Salles, Thomas E. Witzig, Pier Luigi Zinzani, George W. Wright, Louis M. Staudt, Yandan Yang, P. Mickey Williams, Chih-Jian Lih, Jacqueline Russo, Anjan Thakurta, Patrick R. Hagner, Pierre Fustier, Dale Song, Ian D. Lewis

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs

    Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs by Shruthi Subramanian, Julie A.I. Thoms, Yizhou Huang, C. Páramo, Forrest Koch, Sébastien Jacquelin, Sylvie Shen, Emma Song, Swapna Joshi, Chris Brownlee, Petter Woll, Diego Chacon, Dominik Beck, David J. Curtis, Kenneth Yehson, Vicki Antonenas, Tracey O’Brien, Annette Trickett, Jason A. Powell, Ian D. Lewis, Stuart M. Pitson, Maher K. Gandhi, Steven Lane, Fatemeh Vafaee, Emily Wong, Berthold Göttgens, Hamid Alinejad-Rokny, Jason W.H. Wong, John E. Pimanda

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

    Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies by Maya Lewinsohn, Anna Brown, Luke M. Weinel, Connie Phung, George Rafidi, Ming K. Lee, Andreas Schreiber, Jinghua Feng, Milena Babic, Chan‐Eng Chong, Young Kyung Lee, Agnes S. M. Yong, Graeme Suthers, Nicola Poplawski, Meryl Altree, Kerry Phillips, Louise Jaensch, Miriam Fine, Richard J. D’Andrea, Ian D. Lewis, Bruno C. Medeiros, Daniel A. Pollyea, Mary‐Claire King, Tom Walsh, Sioḃán Keel, Akiko Shimamura, Lucy A. Godley, Christopher N Hahn, Jane E. Churpek, Hamish S. Scott

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse by Mark J. Levis, Farhad Ravandi, Eunice S. Wang, Maria R. Baer, Alexander E. Perl, Steven Coutré, Harry P. Erba, Robert K. Stuart, Michele Baccarani, Larry D. Cripe, Martin S. Tallman, Giovanna Meloni, Lucy A. Godley, Amelia Langston, Sergio Amadori, Ian D. Lewis, Arnon Nagler, Richard M. Stone, Karen Yee, Anjali S. Advani, Dan Douer, W Wiktor-Jędrzejczak, Gunnar Juliusson, Mark R. Litzow, Stephen H. Petersdorf, Miguel Á. Sanz, Hagop M. Kantarjian, Takashi Sato, Lothar Tremmel, Debra M. Bensen-Kennedy, Donald Small, B. Douglas Smith

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia by Sheng Li, Francine E. Garrett-Bakelman, Stephen S. Chung, Mathijs A. Sanders, Todd Hricik, Franck Rapaport, Jay Patel, Richard Dillon, Priyanka Vijay, Anna Brown, Alexander E. Perl, Joy Cannon, Lars Bullinger, Selina M. Luger, Michael W. Becker, Ian D. Lewis, Luen Bik To, Ruud Delwel, Bob Löwenberg, Hartmut Döhner, Konstanze Döhner, Mónica L. Guzmán, Duane C. Hassane, Gail J. Roboz, David Grimwade, Peter J.M. Valk, Richard J. D’Andrea, Martin Carroll, Christopher Y. Park, Donna Neuberg, Ross L. Levine, Ari Melnick, Christopher E. Mason

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

    Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Underg... by Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold B. Rybka, Andrew Artz, David L. Porter, Thomas C. Shea, Michael W. Boyer, Richard T. Maziarz, Paul Shaughnessy, Usama Gergis, Hana Safah, Ran Reshef, John F. DiPersio, Patrick J. Stiff, Madhuri Vusirikala, Jeff Szer, Jennifer Holter‐Chakrabarty, James D. Levine, Paul J. Martin, Joseph A. Pidala, Ian D. Lewis, Vincent T. Ho, Edwin P. Alyea, Jerome Ritz, Frank Glavin, Peter Westervelt, Madan Jagasia, Yi‐Bin Chen

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

    Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and min... by Veronika Bachanová, D I Marks, M-J Zhang, Hai‐Lin Wang, Marcos de Lima, Mahmoud Aljurf, Martha Arellano, Andrew Artz, Ulrike Bacher, J-Y Cahn, Y-B Chen, Edward A. Copelan, William R. Drobyski, Robert Peter Gale, John P. Greer, Vikas Gupta, Gregory A. Hale, Partow Kebriaei, Hillard M. Lazarus, Ian D. Lewis, Victor Lewis, Jane L. Liesveld, Mark R. Litzow, Alison W. Loren, Alan M. Miller, Maxim Norkin, Betül Oran, Joseph Pidala, Jacob M. Rowe, Bipin N. Savani, Wael Saber, Ravi Vij, Edmund K. Waller, Peter H. Wiernik, Daniel J. Weisdorf

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research

    Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Resear... by Vikas Gupta, Adriana K. Malone, Parameswaran Hari, Kwang Woo Ahn, Zhen‐Huan Hu, Robert Peter Gale, Karen K. Ballen, Mehdi Hamadani, Eduardo Olavarría, Aaron T. Gerds, Edmund K. Waller, Luciano J. Costa, Joseph H. Antin, Rammurti T. Kamble, Koen M. Van Besien, Bipin N. Savani, Harry C. Schouten, Jeff Szer, Jean‐Yves Cahn, Marcos J. de Lima, Baldeep Wirk, Mahmoud Aljurf, Uday Popat, Nelli Bejanyan, Mark R. Litzow, Maxim Norkin, Ian D. Lewis, Gregory A. Hale, Ann E. Woolfrey, Alan M. Miller, Celalettin Üstün, Madan Jagasia, Michael Lill, Richard T. Maziarz, Jorge E. Cortés, Matt Kalaycio, Wael Saber

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

    GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes by Y-B Chen, T Wang, Michael Hemmer, Claire Brady, Daniel R. Couriel, Amin M. Alousi, Joseph Pidala, Álvaro Urbano-Ispízua, Sung Won Choi, Taiga Nishihori, Takanori Teshima, Yoshihiro Inamoto, Baldeep Wirk, D I Marks, Hisham Abdel‐Azim, Leslie E. Lehmann, Lolie C. Yu, Menachem Bitan, Mitchell S. Cairo, Muna Qayed, Rachel B. Salit, Gale Rp, Rodrigo Martino, Samantha Jaglowski, Ashish Bajel, Bipin N. Savani, Haydar Frangoul, Ian D. Lewis, Jan Storek, Medhat Askar, M A Kharfan-Dabaja, Mahmoud Aljurf, Olle Ringdén, Ran Reshef, Richard F. Olsson, Shahrukh K. Hashmi, Sachiko Seo, Thomas R. Spitzer, Margaret L. MacMillan, Aleksandr Lazaryan, Stephen R. Spellman, Mukta Arora, Corey Cutler

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Genomic subtyping and therapeutic targeting of acute erythroleukemia

    Genomic subtyping and therapeutic targeting of acute erythroleukemia by Ilaria Iacobucci, Ji Wen, Manja Meggendorfer, John Choi, Lei Shi, Stanley Pounds, Catherine Carmichael, Katherine E. Masih, Sarah M. Morris, R. Coleman Lindsley, Laura J. Janke, Thomas Alexander, Guangchun Song, Chunxu Qu, Yongjin Li, Debbie Payne-Turner, Daisuke Tomizawa, Nobutaka Kiyokawa, Marcus B. Valentine, Virginia Valentine, Giuseppe Basso, Franco Locatelli, Eric J. Enemark, Shirley Kow Yin Kham, Allen Eng Juh Yeoh, Xiaotu Ma, Xin Zhou, Edgar Sioson, Michael Rusch, Rhonda E. Ries, Elliot Stieglitz, Stephen P. Hunger, Andrew H. Wei, L.B. To, Ian D. Lewis, Richard J. D’Andrea, Benjamin T. Kile, Anna Brown, Hamish S. Scott, Christopher N Hahn, Paula Marlton, Deqing Pei, Cheng Cheng, Mignon L. Loh, Benjamin L. Ebert, Soheil Meshinchi, Torsten Haferlach, Charles G. Mullighan

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: